NAFDAC Recalls Cough Syrup Over Toxicity Concerns

The National Agency for Food and Drugs Administration and Control (NAFDAC) has recalled Benylin Paediatrics Syrup manufactured by Johnson & Johnson following recent toxicity findings in the laboratory on the product.

The agency said on its website yesterday the laboratory analysis conducted on the product showed that it contains an unacceptable high level of Diethylene glycol and was found to cause acute oral toxicity in laboratory animals.

A product recall is an important method of managing risks in response to product safety events and emergencies.

According to an online health portal, Science Direct, a product recall is a request to return to the maker, a batch, or an entire production run of a product, usually over safety concerns, design defects, or labelling errors.

It said: “Benylin Paediatric syrup is indicated for the relief of cough and its congestive symptoms and for the treatment of hay fever and other allergic conditions in children aged two to 12 years. “Diethylene glycol is toxic to humans when consumed and can prove fatal.

“Toxic effects can include abdominal pain, vomiting, diarrhea, inability to pass urine, headache, altered mental state, and acute kidney injury which may lead to death.” The details of the product showed that the product is manufactured by Johnson & Johnson in Cape Town, South Africa.

With batch number 329304, the product was manufactured in May 2021, and it is to expire this month, April 2024. NAFDAC, however, implored importers, distributors, retailers, and consumers to exercise caution and vigilance within the supply chain to avoid the importation, distribution, sale, and use of substandard (contaminated) regulated products.

It said all medical products must be obtained from authorised/ licensed suppliers. The products’ authenticity and physical condition should be carefully checked.